The bioinorganic and medicinal chemistry of carboranes: from new drug discovery to molecular imaging and therapy.

The role of carboranes in medicinal chemistry has diversified in recent years and now extends into areas of drug discovery, molecular imaging, and targeted radionuclide therapy. An introduction to carborane chemistry is provided to familiarize the non-expert with some key properties of these molecules, followed by an overview of current medicinally-orientated research involving carboranes. The broad-ranging nature of this research is illustrated, with emphasis placed on recent highlights and advances in this field.

[1]  N. Hosmane,et al.  Recent Developments in Boron Neutron Capture Therapy (BNCT) Driven by Nanotechnology , 2007 .

[2]  L. J. Perry,et al.  Synthesis and evaluation of transthyretin amyloidosis inhibitors containing carborane pharmacophores , 2007, Proceedings of the National Academy of Sciences.

[3]  L. Deng,et al.  A Journey from 12-Vertex to 14-Vertex Carboranes and to 15-Vertex Metallacarboranes , 2007 .

[4]  L. Rendina,et al.  Boronated DNA-binding compounds as potential agents for boron neutron capture therapy. , 2007, Mini reviews in medicinal chemistry.

[5]  Andrea F Armstrong,et al.  Microwave-assisted synthesis of tricarbonyl rhenacarboranes: steric and electronic effects on the 1,2 --> 1,7 carborane cage isomerization. , 2007, Inorganic chemistry.

[6]  C. Powell,et al.  Closo --> nido cage degradation of 1-(substituted-phenyl)-1,2-dicarbadodecaborane(12)s in wet DMSO under neutral conditions , 2007 .

[7]  M. Roforth,et al.  Synthesis of functionalized carboranes as potential anticancer and BNCT agents. , 2007, Inorganic chemistry.

[8]  A. V. Orlova,et al.  A universal approach to the synthesis of carbohydrate conjugates of polyhedral boron compounds as potential agents for boron neutron capture therapy , 2006, Russian Journal of Bioorganic Chemistry.

[9]  S. Eriksson,et al.  Hydrophilically enhanced 3-carboranyl thymidine analogues (3CTAs) for boron neutron capture therapy (BNCT) of cancer. , 2006, Bioorganic & medicinal chemistry.

[10]  I. Zharov,et al.  Polyester-based carborane-containing dendrons. , 2006, Inorganic chemistry.

[11]  K. Ono,et al.  Transferrin-loaded nido-carborane liposomes: tumor-targeting boron delivery system for neutron capture therapy. , 2006, Bioconjugate chemistry.

[12]  S. Ohta,et al.  m-Carborane bisphenol structure as a pharmacophore for selective estrogen receptor modulators. , 2006, Bioorganic & medicinal chemistry letters.

[13]  S. Cherry.  Multimodality in vivo imaging systems: twice the power or double the trouble? , 2006, Annual review of biomedical engineering.

[14]  Andrea F Armstrong,et al.  Microwave-assisted synthesis of 3,1,2- and 2,1,8-Re(I) and 99mTc(I)-metallocarborane complexes. , 2006, Inorganic chemistry.

[15]  L. Deng,et al.  Nickel-mediated regioselective [2 + 2 + 2] cycloaddition of carboryne with alkynes. , 2006, Journal of the American Chemical Society.

[16]  J. Macháček,et al.  Computational Studies of Structures and Properties of Metallaboranes. 2. Transition-Metal Dicarbollide Complexes , 2006 .

[17]  M. Hawthorne,et al.  Closomers of high boron content: synthesis, characterization, and potential application as unimolecular nanoparticle delivery vehicles for boron neutron capture therapy. , 2006, Inorganic chemistry.

[18]  M. Bradley,et al.  Polyborane reactions in ionic liquids , 2006 .

[19]  S. Ohta,et al.  Design and synthesis of novel androgen receptor antagonists with sterically bulky icosahedral carboranes. , 2005, Bioorganic & medicinal chemistry.

[20]  S. Morzenti,et al.  Optimisation study of alpha-cyclotron production of At-211/Po-211g for high-LET metabolic radiotherapy purposes. , 2005, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[21]  J. Valliant,et al.  Synthesis of ortho- and meta-Re(I)-metallocarboranes in water. , 2005, Inorganic chemistry.

[22]  Steven M. Johnson,et al.  Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses. , 2005, Accounts of chemical research.

[23]  P. Jelliss,et al.  Similar luminescent behavior in an established rhenacarborane complex, [3,3-(CO)2-3-NO-closo-3,1,2-ReC2B9H11] and a new complex anion, [3,3,3-(CO)3-8-I-closo-3,1,2-ReC2B9H10]- , 2005 .

[24]  Y. Hashimoto,et al.  Potent androgen antagonists based on carborane as a hydrophobic core structure. , 2005, Journal of medicinal chemistry.

[25]  V. Tolmachev,et al.  Radiobromination of closo‐carboranes using palladium‐catalyzed halogen exchange , 2005 .

[26]  D. Wilbur,et al.  Radiohalogens for imaging and therapy. , 2005, Chemical Society reviews.

[27]  Y. Hashimoto,et al.  A new class of androgen receptor antagonists bearing carborane in place of a steroidal skeleton. , 2005, Bioorganic & medicinal chemistry letters.

[28]  H. Kagechika,et al.  Novel retinoid X receptor (RXR) antagonists having a dicarba-closo-dodecaborane as a hydrophobic moiety. , 2004, Bioorganic & medicinal chemistry letters.

[29]  A. Bruskin,et al.  Preparation, radioiodination and in vitro evaluation of a nido-carborane-dextran conjugate, a potential residualizing label for tumor targeting proteins and peptides , 2004 .

[30]  J. Brennan,et al.  Bridging the gap between in vitro and in vivo imaging: isostructural Re and 99mTc complexes for correlating fluorescence and radioimaging studies. , 2004, Journal of the American Chemical Society.

[31]  M. Bradley,et al.  Polyborane reactions in ionic liquids: new efficient routes to functionalized decaborane and o-carborane clusters. , 2004, Journal of the American Chemical Society.

[32]  R. Vessella,et al.  Biotin reagents in antibody pretargeting. 6. Synthesis and in vivo evaluation of astatinated and radioiodinated aryl- and nido-carboranyl-biotin derivatives. , 2004, Bioconjugate chemistry.

[33]  J. Valliant,et al.  Preparation of Re(I)- and (99m)Tc(I)-metallocarboranes in water under weakly basic reaction conditions. , 2004, Inorganic chemistry.

[34]  V. Tolmachev,et al.  High yield [125 I]Iodide-Labeling of Iodinated Carboranes By Palldium-Catalyzed Isotopic Exchange , 2003 .

[35]  V. Tolmachev,et al.  Feasibility of palladium-catalyzed isotopic exchange between sodium [125I]I and 2-iodo-para-carborane , 2003 .

[36]  N. Hosmane.  Recent advances in the chemistry of carboranes and metallacarboranes , 2003 .

[37]  W. Xu,et al.  Design and synthesis of aminophenol-based factor Xa inhibitors. , 2002, Bioorganic & medicinal chemistry letters.

[38]  J. Ko,et al.  Chemistry of o-carboranyl derivatives , 2001 .

[39]  S. Kang,et al.  Synthesis and reactivity of an efficient 1,2-dehydrocarborane precursor, phenyl[o-(trimethylsilyl)carboranyl]iodonium acetate. , 2001, Chemical communications.

[40]  T. Bäck,et al.  Dry-distillation of astatine-211 from irradiated bismuth targets: a time-saving procedure with high recovery yields. , 2001, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[41]  A. Itai,et al.  Structure-Activity study of retinoid agonists bearing substituted dicarba-closo-dodecaborane. Relation between retinoidal activity and conformation of two aromatic nuclei. , 2001, Bioorganic & medicinal chemistry letters.

[42]  G. Henriksen,et al.  Optimisation of cyclotron production parameters for the 209Bi(alpha, 2n) 211At reaction related to biomedical use of 211At. , 2001, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[43]  S. Cherry,et al.  Fundamentals of Positron Emission Tomography and Applications in Preclinical Drug Development , 2001, Journal of clinical pharmacology.

[44]  Yue Su,et al.  Tantalum-Mediated Oxidative Coupling of C2B9H112- Ligands. Synthesis and Characterization of {(μ-H)(C2B9H10)2}TaCl2 , 2000 .

[45]  H. Kagechika,et al.  Polymethylcarborane as a novel bioactive moiety: derivatives with potent retinoid antagonistic activity. , 2000, Bioorganic & medicinal chemistry letters.

[46]  R. Grimes.  Metallacarboranes in the new millennium , 2000 .

[47]  Y. Endo,et al.  Estrogenic antagonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore. , 1999, Bioorganic & medicinal chemistry letters.

[48]  A. Itai,et al.  Structure-activity study of estrogenic agonists bearing dicarba-closo-dodecaborane. Effect of geometry and separation distance of hydroxyl groups at the ends of molecules. , 1999, Bioorganic & medicinal chemistry letters.

[49]  G. Knudsen,et al.  Synthesis of 3-Amino-1-carboxy-o-carborane and an Improved, General Method for the Synthesis of All Three C-Amino-C-carboxycarboranes. , 1999, Inorganic chemistry.

[50]  K. Shudo,et al.  Potent estrogenic agonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore. , 1999, Journal of medicinal chemistry.

[51]  Zbigniew Dauter,et al.  Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.

[52]  J. E. Jackson,et al.  Reactions of 1,2-Dehydro-o-carborane with Thiophenes. Cycloadditions and an Easy Synthesis of "Benzo-o-carboranes"(1). , 1996, Inorganic chemistry.

[53]  M. Zalutsky,et al.  Evaluation of an internal cyclotron target for the production of 211At via the 209Bi (α,2n)211At reaction , 1996 .

[54]  Allan Fletcher,et al.  Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist , 1995, Behavioural Brain Research.

[55]  J. Brewer,et al.  REACTION OF 1,2-DEHYDRO-O-CARBORANE WITH ACETYLENES. SYNTHESIS AND STRUCTURE OF A CARBORANE ANALOGUE OF BENZOCYCLOBUTADIENE1 , 1995 .

[56]  D. Ciocca,et al.  Estrogen receptors in human nontarget tissues: biological and clinical implications. , 1995, Endocrine reviews.

[57]  V. I. Bregadze,et al.  Dicarba-closo-dodecaboranes C2B10H12 and their derivatives , 1992 .

[58]  S. Heřmánek.  Boron-11 NMR spectra of boranes, main-group heteroboranes, and substituted derivatives. Factors influencing chemical shifts of skeletal atoms , 1992 .

[59]  L. Leites.  Vibrational spectroscopy of carboranes and parent boranes and its capabilities in carborane chemistry , 1992 .

[60]  R. Williams.  The Polyborane, Carborane, Carbocation Continuum: Architectural Patterns , 1992 .

[61]  R. Paxton,et al.  A transition metal complex (Venus flytrap cluster) for radioimmunodetection and radioimmunotherapy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[62]  Maitland Jones,et al.  Reactions of 1,2-dehydro-o-carborane with dienes , 1991 .

[63]  Maitland Jones,et al.  1,2-Dehydro-o-carborane , 1990 .

[64]  M. Hawthorne,et al.  Synthesis and antibody-labeling studies with the p-isothiocyanatobenzene derivatives of 1,2-dicarba-closo-dodecarborane(12) and the dodecahydro-7,8-dicarbanido-undecaborate(-1) ion for neutron-capture therapy of human cancer. Crystal and molecular structure of Cs+[nido-7-(p-C6H4NCS)-9-I-7,8-C2B9H11] , 1985 .

[65]  W. Eckelman,et al.  Instant 99mTc-DTPA. , 1970, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[66]  F. S. Yakushin,et al.  The equilibrium and kinetic acidities of isomeric carborane methines , 1970 .

[67]  M. Hawthorne,et al.  Reconstruction of the 1,2-dicarbaclovododecaborane(12) structure by boron-atom insertion with (3)-1,2-dicarbollide ions , 1968 .

[68]  M. Hawthorne,et al.  Halodicarbaundecaborate(11) Ions , 1965 .

[69]  M. Hawthorne,et al.  B-Phenyl-1,2-dicarbaclovododecaborane(12) from B9C2H11-2through an Insertion Reaction , 1965 .

[70]  M. Hawthorne,et al.  Carbametallic Boron Hydride Derivatives. II. Apparent Analogs of π-C5H5Mn(CO)3 and π-C5H5Re(CO)3 , 1965 .

[71]  T. L. Heying,et al.  p-Carborane [1,12-Dicarbaclovododecaborane(12)] , 1964 .

[72]  T. L. Heying,et al.  A New Series of Organoboranes. I. Carboranes from the Reaction of Decaborane with Acetylenic Compounds , 1963 .

[73]  M. Fein,et al.  Carboranes. II. The Preparation of 1- and 1,2-Substituted Carboranes , 1963 .

[74]  T. L. Heying,et al.  A New Series of Organoboranes. III. Some Reactions of 1,2-Dicarbaclovododecaborane(12) and its Derivatives , 1963 .

[75]  D. Grafstein,et al.  Neocarboranes, a New Family of Stable Organoboranes Isomeric with the Carboranes , 1963 .

[76]  O. Chiewitz,et al.  Radioactive Indicators in the Study of Phosphorus Metabolism in Rats , 1935, Nature.

[77]  R. Vessella,et al.  Reagents for astatination of biomolecules: comparison of the in vivo distribution and stability of some radioiodinated/astatinated benzamidyl and nido-carboranyl compounds. , 2004, Bioconjugate chemistry.

[78]  M. A. Fox,et al.  Synthesis of isomeric B-methylated tantalum carboranes, (Me2N)3TaC2B9H10Me , 2001 .

[79]  N. Hosmane,et al.  METALLABORANES AND METALLACARBORANES OF s-BLOCK ELEMENTS , 2000 .

[80]  Andrew L. Johnson,et al.  First structural characterisation of a 2,1,12-MC2B9 metallacarborane, [2,2,2-(NMe2)3-closo-2,1,12-TaC2B9H11]. Trends in boron NMR shifts on replacing a {BH} vertex with a metal {MLn} vertex in icosahedral carboranes , 2000 .

[81]  M. A. Fox,et al.  Fluoride-ion deboronation of p-fluorophenyl-ortho- and -meta-carboranes. NMR evidence for the new fluoroborate, HOBHF2− , 1997 .

[82]  N. N. Greenwood,et al.  Polyhedral metallacarbaborane chemistry: preparation, molecular structure, and nuclear magnetic resonance investigation of [3-(η5-C5Me5)-closo-3,1,2-MC2B9H11] (M = Rh or Ir) , 1990 .

[83]  W. Hutton,et al.  Two-dimensional boron-11−boron-11 nuclear magnetic resonance spectroscopy as a probe of polyhedral structure: application to boron hydrides, carboranes, metallaboranes, and metallacarboranes , 1984 .